Well tolerated in topical applications
Sermorelin was previously FDA-approved for treating growth hormone deficiencies in children but was discontinued by the manufacturer for commercial reasons, not safety concerns
If youre unsure whether youre experiencing allergies or pregnancy rhinitis, the timing and duration of your symptoms might help
This reflects the judiciarys recognition that vision loss claims raise distinct factual and legal issues requiring focused coordination
The 0.5 mg dose represents an intermediate step rather than a target endpoint for most patients seeking significant weight reduction
Orforglipron showed stronger effects on blood sugar control, HDL cholesterol, and systolic blood pressure, while semaglutide showed larger effects on total body weight, waist circumference, and LDL cholesterol